High-dose extended-release calcifediol successfully treated advanced secondary hyperparathyroidism in an end-stage kidney disease patient: a case report.

Saved in:
Bibliographic Details
Title: High-dose extended-release calcifediol successfully treated advanced secondary hyperparathyroidism in an end-stage kidney disease patient: a case report.
Authors: Ashfaq A; OPKO Health, Miami, FL, USA., Choe J; OPKO Health, Miami, FL, USA., Tabash S; MHN Pharma Consulting, Whitby, ON, Canada., Strugnell SA; OPKO Health, Miami, FL, USA., Johnson LL; Next Generation Clinical Research, Madison, WI, USA., Bishop CW; OPKO Health, Miami, FL, USA. cbishop@opko.com.; OPKO Renal Division, 4400 Biscayne Blvd, Miami, FL, 33137, USA. cbishop@opko.com.
Source: BMC nephrology [BMC Nephrol] 2025 Aug 07; Vol. 26 (1), pp. 442. Date of Electronic Publication: 2025 Aug 07.
Publication Type: Journal Article; Case Reports
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967793 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2369 (Electronic) Linking ISSN: 14712369 NLM ISO Abbreviation: BMC Nephrol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1471-2369
DOI:10.1186/s12882-025-04361-3